Clinical trials
Urogenital Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 10 |
| Terminated | 4 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 6 |
| M.D. Anderson Cancer Center | 3 |
| National Center for Research Resources (NCRR) | 3 |
| Astellas Pharma Global Development, Inc. | 2 |
| Emory University | 2 |
| Anova Enterprises, Inc | 1 |
| Audubon Bioscience | 1 |
| Children's Hospital Los Angeles | 1 |
| FDA Office of Orphan Products Development | 1 |
| Georgetown University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Diseases | 32 |
| Rare Diseases | 12 |
| Neoplasms | 8 |
| Female Urogenital Diseases | 6 |
| Male Urogenital Diseases | 6 |
| Prostatic Neoplasms | 6 |
| Communicable Diseases | 4 |
| Glomerulonephritis, IGA | 4 |
| Kidney Diseases | 4 |
| Kidney Failure, Chronic | 4 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.